FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry, namely to creation of medication for reduction of fat absorption form food, containing pectin or its salts, inhibitor of gastrointestinal lipase, auxiliary components.
EFFECT: medication is used for treatment or prevention of syndrome of anal oil leks, which can take place after administration of gastrointestinal lipase inhibitor of orlistat type, with further application for treatment of obesity and hyperlipemia.
6 cl, 4 dwg, 8 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR REDUCING ABSORPTION OF DIETARY FAT | 2011 |
|
RU2566050C2 |
MEDICINAL AGENT "GASTROPEK" FOR IMPROVING DIGESTION PROCESS AND METHOD FOR ITS USING | 2004 |
|
RU2276974C2 |
METHOD FOR INCREASING THE PRODUCTIVE QUALITIES OF CATTLE BY INTRODUCING A FEED ADDITIVE | 2021 |
|
RU2781992C1 |
METHOD OF BULL-CALVES FEED IN ECOLOGICALLY CONTAMINATED AND POLLUTED LANDS | 2009 |
|
RU2402206C1 |
PHARMACEUTICAL COMPOSITION CONTAINING LIPASE INHIBITOR AND GLUCOMANNAN | 2003 |
|
RU2297221C2 |
METHOD FOR PATIENT-SPECIFIC PREDICTION OF OESTROGEN-DEPENDENT DISEASES IN HEALTHY FEMALES AND FEMALES WITH CARDIOVASCULAR RISK FACTORS AGED 35-45 YEARS | 2013 |
|
RU2536829C1 |
PEPTIDE WITH ANTI-OBESITY AND ANTIDIABETIC EFFICACY AND USE THEREOF | 2017 |
|
RU2721426C1 |
DISPERSION COMPOSITION CONTAINING LIPASE INHIBITORS | 2000 |
|
RU2239428C2 |
SOLID LIPID COMPOSITIONS | 2000 |
|
RU2248218C2 |
METHOD FOR CREATING TRANSLATIONAL MODEL OF DIABETIC PHENOTYPE OF CHRONIC HEART FAILURE | 2023 |
|
RU2817822C1 |
Authors
Dates
2011-02-27—Published
2009-05-14—Filed